Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2020-05-04 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections regarding the 'Notification of Major Holdings' by BlackRock, Inc., referencing specific German securities laws (WpHG, Sec. 40, Sec. 33, Sec. 34). It details the acquisition/disposal of shares with voting rights and the resulting total positions (in percentages and absolute numbers) as of April 24, 2020. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels crossing a threshold, which maps to the 'Major Shareholding Notification' category (MRQ).
2020-05-04 English
Invitation to MorphoSys' First Quarter 2020 Results Conference Call on May 7, 2020 (news with additional features)
Report Publication Announcement Classification · 1% confidence The document is an official announcement titled "Invitation to MorphoSys’ First Quarter 2020 Results Conference Call on May 7, 2020". It explicitly details the date, time, dial-in numbers, and PIN for an upcoming conference call where the company will present its Q1 2020 results. This content is characteristic of an announcement inviting participants to an earnings-related discussion, which aligns perfectly with the definition of a Call Transcript (CT) if it were the transcript itself, or more accurately, an announcement leading up to a call. Since the document is an invitation and provides details for accessing the call where results will be discussed, it is most closely related to the event itself. However, none of the definitions perfectly capture an *invitation* to an earnings call. Let's re-evaluate the options: 1. ER (Earnings Release): This is usually the press release containing the key financial figures, which precedes the call. This document announces the call, not the results themselves (which are published the day before). 2. CT (Call Transcript): This is the transcript of the call, not the invitation. 3. RPA (Report Publication Announcement): This is for announcing the publication of a report, not a conference call. Given that the core purpose is to facilitate participation in the discussion of quarterly results, it is highly related to the Earnings Release (ER) process, but it is specifically an invitation to the *call*. In many classification schemes, an invitation to an earnings call is often grouped with the Earnings Release (ER) or sometimes treated as a general Regulatory Filing (RNS) if no better fit exists. Since the call is specifically to present the 'First Quarter 2020 Results', it is intrinsically linked to the earnings event. If the document were the actual results, it would be ER. Since it is the invitation to discuss those results, it is a precursor/related event announcement. Given the options, and recognizing that this is an announcement about the mechanism for discussing earnings, it is closest to the context of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is a specific announcement about a scheduled event (the conference call), and not a general regulatory filing, I will lean towards the category that best describes the *subject matter* of the call, which is the quarterly results discussion. However, the most precise fit for an announcement *about* a conference call, especially one that is not the transcript, is often the Call Transcript (CT) category if the system uses it broadly for call-related materials, or RNS. Reviewing the definitions again: CT is 'Full text transcript of company conference calls'. This is an invitation. ER is 'Initial announcement of quarterly/periodical financial results (key highlights only)'. This document announces the call to discuss those results. Since the document is an invitation to discuss the Q1 results, and the Q1 results themselves would likely be an ER, this announcement serves as the logistical setup for the earnings discussion. In the absence of a specific 'Conference Call Invitation' code, and noting that the document is short and focused on logistics for an earnings event, I will classify it as a Call Transcript (CT) as it is the closest category related to the conference call event itself, although it is technically the invitation, not the transcript. Alternatively, RNS is the fallback. Given the high specificity of the other codes, and the focus on the call, CT is a plausible, though imperfect, fit for call-related logistics announcements when a dedicated code is missing. I will use RNS as the safest fallback for a specific event announcement that doesn't fit the primary report/release codes. Revisiting the context: This is an invitation to discuss Q1 results. If the results were attached, it would be ER. Since it's an invitation to the *call*, and the call is the primary mechanism for discussion, I will select CT, assuming the system groups call-related announcements here, or RNS. Given the structure, it is a specific corporate announcement disseminated via DGAP, making RNS a strong candidate. However, because the subject is explicitly a conference call, CT is contextually stronger than the general RNS fallback, even if it's not the transcript itself. Let's check if there's a better fit. No. I will stick with CT as it relates directly to the conference call event. Final decision: The document is an invitation to the conference call where Q1 results will be discussed. This is most closely associated with the Call Transcript (CT) category, which covers conference calls.
2020-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in voting rights percentages held by BlackRock, Inc., crossing a threshold. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns with the 'Major Shareholding Notification' category (MRQ). Although it is a regulatory filing, MRQ is more specific than the general RNS fallback.
2020-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in the percentage of voting rights held by BlackRock, Inc. in MorphoSys AG, crossing a threshold. This content directly corresponds to the definition of a notification regarding changes in significant share ownership levels. Comparing this to the provided definitions: - It is not an Annual Report (10-K), Earnings Release (ER), or Interim Report (IR). - It is specifically about changes in share ownership/voting rights by a major shareholder, which aligns perfectly with the 'Major Shareholding Notification' category. - The code for Major Shareholding Notification is MRQ.
2020-04-29 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings') by a specific entity (FMR LLC) in MorphoSys AG, referencing German Securities Trading Act (WpHG) sections. This directly corresponds to the definition of reporting changes in significant share ownership thresholds. The filing type code 'MRQ' (Major Shareholding Notification) is the most appropriate classification for this type of regulatory disclosure regarding ownership changes.
2020-04-28 English
MorphoSys and I-Mab Announce First Patient Dosed in Phase 3 Clinical Trial of MOR202/TJ202 in r/r Multiple Myeloma in Mainland ChinaMorphoSys AG: (news with additional features)
Regulatory Filings Classification · 1% confidence The document is a press release dated April 27, 2020, announcing that the first patient has been dosed in a Phase 3 clinical trial for a drug (MOR202/TJ202) developed by MorphoSys and I-Mab. It details the study design, partnership terms, and provides company background information. This type of announcement, detailing clinical trial progress and partnership updates, is characteristic of general corporate news releases related to R&D activities. It is not a formal financial report (like 10-K or IR), an earnings release (ER), or a specific regulatory filing like a Director's Dealing (DIRS) or Proxy Statement (PSI). Since it is a general corporate news announcement transmitted by DGAP, and it doesn't fit the specific categories like ER, CT, or AR, the most appropriate general category for significant corporate updates that aren't strictly financial reporting or mandatory regulatory forms is often the general Regulatory Filings (RNS) category, which serves as a broad catch-all for material news releases not covered elsewhere, especially when the content is focused on operational/clinical milestones. Given the options, RNS is the best fit for a material, non-financial, non-meeting related corporate announcement.
2020-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.